Skip to main content

Altimmune, Inc.

ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001326190

In the last 90 days, Altimmune, Inc. insiders filed 4 open-market purchases and 0 sales; 190 institutions reported holding it in 13F filings for Q3 2026, worth $407.4M in total; Viking Global Investors is the only superinvestor holding it.

Key figures

Market capClose on Nov 19, 2026
$274.4M
Insider buysLast 90 days, $96.4K in total
4
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, −16 vs. previous quarter
190
13F valueReported value at the end of Q3 2026
$407.4M
Superinvestors holdingAt the end of Q3 2026
1

Price chart

From SEC filings, in USD.

Revenue, FY2025
$41.0K
+105.0% year over year
Net income, FY2025
-$88.1M
No comparable prior period
Free cash flow, FY2025
-$67.5M
No comparable prior period
Revenue, Q3 FY2026
–
No comparable prior period

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $88.1M (214861.0% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
42.1M
Shares sold short
Change
−102.6K
−0.2% vs. previous
Days to cover
12.16
At average daily volume

Superinvestors holding ALT, Q3 2026

Go to the superinvestors tab

1 superinvestor reports holding Altimmune, Inc. on Form 13F. Percentages are the stock's share of each portfolio.

Viking Global Investors

Andreas Halvorsen

0.1%

Altimmune, Inc.'s share of the portfolio

Shares
6,700,000
Value
$19.2M

Latest insider trades

See all insider trades

Open-market purchases and sales by Altimmune, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2026 (view filing)4:08 PM ETNov 18Same dayMenziuso Richard ThomasPrincipal Accounting OfficerPPurchaseCommon Stock, par value $0.0001+10.0K$1.42+$14.2KNew position10.0K after
Nov 13, 2026 (view filing)4:27 PM ETNov 13Same dayWeaver Gregory LChief Financial OfficerPPurchaseCommon Stock, par value $0.0001+10.0K$1.62+$16.2K+15.9%73.0K after
Nov 13, 2026 (view filing)4:27 PM ETNov 13Same dayPisano WayneDirectorPPurchaseCommon Stock, par value $0.0001+10.0K$1.64+$16.4K+20.5%58.8K after
Nov 13, 2026 (view filing)4:25 PM ETNov 13Same dayDurso Jerome BenedictPresident and CEOPPurchaseCommon Stock, par value $0.0001+30.7K$1.62+$49.7K+49.1%93.2K after
Aug 13, 2026 (view filing)4:05 PM ETAug 13Same dayDurso Jerome BenedictPresident and CEOPPurchaseCommon Stock, par value $0.0001+15.0K$2.95+$44.3K+31.6%62.5K after
Apr 6, 2026 (view filing)Apr 6Same dayGill JohnDirectorPPurchaseCommon Stock, par value $0.0001+9.20K$3.41+$31.4K+73.6%21.7K after
Apr 1, 2026 (view filing)Apr 1Same dayDurso Jerome BenedictPresident and CEOPPurchaseCommon Stock, par value $0.0001+15.0K$3.14+$47.1K+46.2%47.5K after
Apr 1, 2026 (view filing)Apr 1Same dayWeaver Gregory LChief Financial OfficerPPurchaseCommon Stock, par value $0.0001+10.0K$3.15+$31.5K+35.6%38.1K after
Mar 9, 2026 (view filing)Mar 63 daysDurso Jerome BenedictPresident and CEOPPurchaseCommon Stock, par value $0.0001+20.0K$3.54+$70.8K+160.0%32.5K after
Mar 9, 2026 (view filing)Mar 63 daysWeaver Gregory LChief Financial OfficerPPurchaseCommon Stock, par value $0.0001+5.00K$3.54+$17.7K+21.7%28.1K after

Top 10 13F holders, Q3 2026

See all 190 holders

The largest institutional positions in Altimmune, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding ALT in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.20,960,259$59.9M0.00%+574,975+2.8%Added
Deep Track Capital, LP19,250,000$55.1M0.93%00.0%Unchanged
State Street Corp8,356,408$23.9M0.00%−3,742,132−30.9%Reduced
Vanguard Portfolio Management LLC8,107,554$23.2M0.00%+777,289+10.6%Added
Vanguard Capital Management LLC7,812,919$22.3M0.00%−364,833−4.5%Reduced
Viking Global Investors LPSuperinvestorViking Global Investors6,700,000$19.2M0.06%00.0%Unchanged
Ra Capital Management, L.P.6,500,000$18.6M0.19%00.0%Unchanged
Marshall Wace, LLP5,431,302$15.5M0.01%−1,409,753−20.6%Reduced
Geode Capital Management, LLC4,884,491$14.0M0.00%−126,823−2.5%Reduced
Two Sigma Investments, LP4,241,069$12.1M0.01%+1,859,927+78.1%Added

Holders of 5% or more of ALT

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Altimmune, Inc..

Largest holders of ALT from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Deep Track Capital, LP13G9.99%19.4M sharesNewApr 30, 20261 filingApr 30, 2026SEC
BlackRock, Inc.13G/A7.60%6.13M shares−1.10 ppfrom 8.70%Feb 5, 20252 filingsJul 16, 2025SEC
Viking Global Investors LPSuperinvestorViking Global Investors13G6.70%13.4M sharesNewMay 1, 20261 filingMay 1, 2026SEC
Ra Capital Management, L.P.13G6.50%13.0M sharesNewMay 1, 20261 filingMay 1, 2026SEC